67 related articles for article (PubMed ID: 23102897)
1. Safety and effectiveness of oxaliplatin-based chemotherapy regimens in adults 75 years and older with colorectal cancer.
McCleary NJ; Odejide O; Szymonifka J; Ryan D; Hezel A; Meyerhardt JA
Clin Colorectal Cancer; 2013 Mar; 12(1):62-9. PubMed ID: 23102897
[TBL] [Abstract][Full Text] [Related]
2. Phase I trial of oxaliplatin, infusional 5-fluorouracil, and leucovorin (FOLFOX4) with erlotinib and bevacizumab in colorectal cancer.
Messersmith WA; Jimeno A; Jacene H; Zhao M; Kulesza P; Laheru DA; Kahn Y; Spira A; Dancey J; Iacobuzio-Donahue C; Donehower RC; Carducci M; Rudek MA; Hidalgo M
Clin Colorectal Cancer; 2010 Dec; 9(5):297-304. PubMed ID: 21208844
[TBL] [Abstract][Full Text] [Related]
3. First- and second-line bevacizumab in addition to chemotherapy for metastatic colorectal cancer: a United States-based cost-effectiveness analysis.
Goldstein DA; Chen Q; Ayer T; Howard DH; Lipscomb J; El-Rayes BF; Flowers CR
J Clin Oncol; 2015 Apr; 33(10):1112-8. PubMed ID: 25691669
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors for Thrombocytopenia Induced by Capecitabine Plus Oxaliplatin Therapy in Patients With Colorectal Cancer.
Kato N; Nakai T; Kodama S; Koyama S; Nakane S; Wada Y; Oda H; Katayama H; Mase H; Miyagawa Y; Miyazaki M; Yamada S; Yamada K
In Vivo; 2024; 38(3):1243-1252. PubMed ID: 38688620
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of natural killer cells injection combined with XELOX chemotherapy in postoperative patients with stage III colorectal cancer in China: a prospective randomised controlled clinical trial study protocol.
Geng S; Yu X; Yu S
BMJ Open; 2024 Mar; 14(3):e080377. PubMed ID: 38531576
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide study of genetic polymorphisms predictive for outcome from first-line oxaliplatin-based chemotherapy in colorectal cancer patients.
Park HA; Edelmann D; Canzian F; Seibold P; Harrison TA; Hua X; Shi Q; Silverman A; Benner A; Macauda A; Schneider M; Goldberg RM; Alberts SR; Hoffmeister M; Brenner H; Chan AT; Peters U; Newcomb PA; Chang-Claude J
Int J Cancer; 2023 Nov; 153(9):1623-1634. PubMed ID: 37539667
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant Chemotherapy for Older Patients With Stage III Colorectal Cancer: A Real-World Analysis of Treatment Recommendations, Treatment Administered and Impact on Cancer Recurrence.
Piercey O; Wong HL; Leung C; To YH; Heong V; Lee M; Tie J; Steel M; Yeung JM; McCormick J; Gibbs P; Wong R
Clin Colorectal Cancer; 2024 Mar; 23(1):95-103.e3. PubMed ID: 38242766
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness of Oxaliplatin Versus 5-flourouricil in Older Adults: An Instrumental Variable Analysis.
Mack CD; Brookhart MA; Glynn RJ; Meyer AM; Carpenter WR; Sandler RS; Stürmer T
Epidemiology; 2015 Sep; 26(5):690-9. PubMed ID: 26196683
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Stages, Treatment Protocols, and Outcomes of Colorectal Cancer among West Bank Patients.
Sawaid IO; Samson AO; Al-Ramahi R
J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673557
[No Abstract] [Full Text] [Related]
10. ePRO symptom follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care: a prospective multicenter study.
Iivanainen S; Ravichandra R; Jekunen A; Arokoski R; Mentu S; Lang L; Ekström J; Virtanen H; Kataja V; Koivunen JP
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6875-6882. PubMed ID: 36809503
[TBL] [Abstract][Full Text] [Related]
11. Do treatment patterns differ in those with early-onset colorectal cancer?
Waddell O; Teo Y; Thompson N; McCombie A; Glyn T; Frizelle F
Expert Rev Anticancer Ther; 2024 May; 24(5):313-323. PubMed ID: 38619285
[TBL] [Abstract][Full Text] [Related]
12. Oncological treatment and outcome of colorectal cancer in Greenland.
Odgaard M; Lohse N; Petersen AJ; Bæksgaard L
Int J Circumpolar Health; 2018 Dec; 77(1):1546069. PubMed ID: 30458696
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic Profile and Treatment Outcomes of Colorectal Cancer in Young Adults: A Multicenter Study From India.
Sehrawat A; Khanna M; Kayal S; Sundriyal D; Tiwari S; Cyriac S; Ravishankaran P; Raphael J; Mathew D; Panda SS; Moharana L; Mohanty SS; Mohanty SS; Philips A; Jain D; Jeyaraj P; David PH; Patil J; Saju SV; Rathnam K; Sharma N; Dheva K; Jinkala SR; Raja K; Penumadu P; Ganesan P
JCO Glob Oncol; 2024 May; 10():e2300225. PubMed ID: 38754051
[TBL] [Abstract][Full Text] [Related]
14. Toxicities and Associated Factors in Patients Receiving Temozolomide-Containing Regimens: A 12-Year Analysis of Hospital Data.
Shi C; Wang X; Diao C; Zhu H; Yuan Q; Liu J; Li S; Gu M; Zhang Y
Drug Des Devel Ther; 2021; 15():2151-2159. PubMed ID: 34045849
[TBL] [Abstract][Full Text] [Related]
15. Emergency presentation of colorectal cancer in older adults: A retrospective cohort analysis.
Nobes JH; Baxter MA; Mowat C
J Geriatr Oncol; 2024 Apr; 15(5):101780. PubMed ID: 38678774
[TBL] [Abstract][Full Text] [Related]
16. Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients: findings from CALGB 89803 and CALGB 80405.
Van Loon K; Wigler D; Niedzwiecki D; Venook AP; Fuchs C; Blanke C; Saltz L; Goldberg RM; Meyerhardt JA
Clin Colorectal Cancer; 2013 Jun; 12(2):95-102. PubMed ID: 23317558
[TBL] [Abstract][Full Text] [Related]
17. Novel chromium (III)-based compound for inhibition of oxaliplatin-resistant colorectal cancer progression.
Chen MC; Devi HS; Pien HF; Wen SF; Sheu JL; Tsai BC; Huang CY; Lin YJ
Am J Cancer Res; 2024; 14(3):979-995. PubMed ID: 38590406
[TBL] [Abstract][Full Text] [Related]
18. Type 2 Diabetes Mellitus and Non-Metastatic Colorectal Cancer: A Retrospective Study on Survival and Toxicity Profiles.
Elabd NS; Alabassy MM; Seddik RM; Amer AA; Abdelaziz RA; Sohaib A
Asian Pac J Cancer Prev; 2024 Jan; 25(1):87-94. PubMed ID: 38285771
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer treatment in older patients.
Sanoff HK; Goldberg RM
Gastrointest Cancer Res; 2007 Nov; 1(6):248-53. PubMed ID: 19262903
[TBL] [Abstract][Full Text] [Related]
20. Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure.
Puente A; Fortea JI; Del Pozo C; Serrano M; Alonso-Peña M; Giráldez A; Tellez L; Martinez J; Magaz M; Ibañez L; Garcia J; Llop E; Alvarez-Navascues C; Romero M; Rodriguez E; Arias Loste MT; Antón A; Echavarria V; López C; Albillos A; Hernández-Gea V; Garcia-Pagán JC; Bañares R; Crespo J;
Dig Liver Dis; 2024 May; ():. PubMed ID: 38719628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
